Orexo Management

Management criteria checks 2/4

Orexo's CEO is Nikolaj Sorensen, appointed in Feb 2013, has a tenure of 9.75 years. total yearly compensation is SEK9.85M, comprised of 36.7% salary and 63.3% bonuses, including company stock and options. directly owns 0.28% of the company’s shares, worth SEK1.79M. The average tenure of the management team and the board of directors is 3.8 years and 3.1 years respectively.

Key information

Nikolaj Sorensen

Chief executive officer

kr9.9m

Total compensation

CEO salary percentage36.7%
CEO tenure9.8yrs
CEO ownership0.3%
Management average tenure3.8yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Nikolaj Sorensen's remuneration changed compared to Orexo's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-kr152m

Jun 30 2022n/an/a

-kr177m

Mar 31 2022n/an/a

-kr216m

Dec 31 2021kr10mkr4m

-kr223m

Sep 30 2021n/an/a

-kr207m

Jun 30 2021n/an/a

-kr240m

Mar 31 2021n/an/a

-kr198m

Dec 31 2020kr9mkr3m

-kr84m

Sep 30 2020n/an/a

kr4m

Jun 30 2020n/an/a

kr201m

Mar 31 2020n/an/a

kr288m

Dec 31 2019kr6mkr3m

kr219m

Sep 30 2019n/an/a

kr232m

Jun 30 2019n/an/a

kr182m

Mar 31 2019n/an/a

kr178m

Dec 31 2018kr5mkr3m

kr138m

Sep 30 2018n/an/a

kr113m

Jun 30 2018n/an/a

kr79m

Mar 31 2018n/an/a

kr32m

Dec 31 2017kr6mkr4m

kr23m

Sep 30 2017n/an/a

kr19m

Jun 30 2017n/an/a

kr27m

Mar 31 2017n/an/a

kr29m

Dec 31 2016kr5mkr3m

kr29m

Sep 30 2016n/an/a

-kr57m

Jun 30 2016n/an/a

-kr139m

Mar 31 2016n/an/a

-kr229m

Dec 31 2015kr5mkr3m

-kr210m

Compensation vs Market: Nikolaj's total compensation ($USD940.24K) is above average for companies of similar size in the UK market ($USD348.41K).

Compensation vs Earnings: Nikolaj's compensation has increased whilst the company is unprofitable.


CEO

Nikolaj Sorensen (50 yo)

9.8yrs

Tenure

kr9,851,000

Compensation

Mr. Nikolaj Sørensen serves as Independent Director at Bioservo Technologies AB (publ) since May 6, 2019. He is Director at Gesynta Pharma AB. He has been the Chief Executive Officer of Orexo AB since Febr...


Leadership Team

NamePositionTenureCompensationOwnership
Nikolaj Sorensen
President & CEO9.8yrskr9.85m0.28%
SEK 1.8m
Fredrik Jarrsten
Executive VP & CFOless than a yearno datano data
Cecilia Coupland
Senior VP & Head of Operations3.8yrsno data0.013%
SEK 81.8k
Lena Wange
Investor Relations & Communications Directorno datano datano data
Robert Ronn
Senior VP and Head of R&D3.8yrsno data0.0082%
SEK 51.9k
Dennis Urbaniak
Executive Vice President of Digital Therapeutics2.9yrsno data0.029%
SEK 185.0k
Edward Kim
Chief Medical Officerless than a yearno datano data
Robert Deluca
President of Orexo US Inc9.8yrsno data0.025%
SEK 158.8k
Jesper Lind
no datano datano data

3.8yrs

Average Tenure

53yo

Average Age

Experienced Management: ORXs's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
George Wilkinson
Independent Director3.6yrskr400.00k0.015%
SEK 96.2k
James Noble
Independent Chairman of the Board2.6yrskr1.50m0.081%
SEK 518.0k
Staffan Lindstrand
Independent Director20.8yrskr350.00k0.011%
SEK 68.0k
Michael Matly
Directorless than a yearno datano data
Mary Christie
Independent Director3.6yrskr400.00k0.0034%
SEK 21.3k
Christine Rankin
Directorless than a yearno datano data
Henrik Hansen
Director4.6yrsno datano data
Charlotte Hansson
Independent Director2.6yrskr600.00k0.016%
SEK 101.7k

3.1yrs

Average Tenure

59yo

Average Age

Experienced Board: ORXs's board of directors are considered experienced (3.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.